Sympathetic sudomotor disturbance in early type 1 diabetes mellitus is linked to lipid peroxidation

Metabolism: Clinical and Experimental

Volumn 55, Issue 11, 2006, Pages 1524-1531

  Hoeldtke, Robert D ^a   Bryner, Kimberly D ^a   Hoeldtke, Martin E ^a   Christie, Ian ^b   Ganser, Gary ^b   Hobbs, Gerald ^b   Riggs, Jack ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C; MALONALDEHYDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; ELECTROLYTE EXCRETION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; LOWER LEG; MALE; PERIPHERAL NEUROPATHY; PERONEUS NERVE; PRIORITY JOURNAL; SENSORY ANALYSIS; STATISTICAL SIGNIFICANCE; SWEATING;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; DINOPROST; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPID PEROXIDATION; LONGITUDINAL STUDIES; MALE; MALONDIALDEHYDE; NEURAL CONDUCTION; NITRATES; NOREPINEPHRINE; PERIPHERAL NERVOUS SYSTEM; REGRESSION ANALYSIS; RENIN; SWEATING; VANILMANDELIC ACID;

EID: 33749544154     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.06.023     Document Type: Article

References (39)

1. Nickander K.K., McPhee B.R., Low P.A., et al. Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic Biol Med 21 (1996) 631-639
2. Hoeldtke R.D., Bryner K.D., McNeill D.R., et al. Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes. J Clin Endocrinol Metab 88 (2003) 1624-1628
3. Hoeldtke R.D., Bryner K.D., McNeill D.R., et al. Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes 51 (2002) 2817-2825
4. Nelson G.J., Morris V.C., Schmidt P.C., et al. The urinary excretion of thiobarbituric acid reactive substances and malondialdehyde by normal adult males after consuming a diet containing salmon. Lipids 28 (1993) 757-761
5. Florin T.H.J., Neale G., and Cummings J.H. The effect of dietary nitrate on nitrate and nitrite excretion in man. Br J Nutr 64 (1990) 387-397
6. Jamal G.A., Hansen S., Weir A.L., et al. The neurophysiologic investigation of small fiber neuropathies. Muscle Nerve 10 (1987) 537-545
7. Ewing D.J., Martyn C.N., Young R.J., et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8 (1985) 491-498
8. Akselrod S., Gordon D., Ubel F.A., et al. Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat-to-beat cardiovascular control. Science 213 (1981) 220-222
9. Hoeldtke R.D., Bryner K.D., Komanduri P., et al. Decreased prorenin processing develops before autonomic dysfunction in type 1 diabetes. J Clin Endocrinol Metab 85 (2000) 585-589
10. Hoeldtke R.D., and Cilmi K.M. Norepinephrine secretion and production in diabetic autonomic neuropathy. J Clin Endocrinol Metab 59 (1984) 246-252
11. Low P.A., Caskey P.E., Tuck R.R., et al. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 14 (1983) 573-580
12. Aleyassine H., Gardiner R.J., Blankstein L.A., et al. Agar gel electrophoretic determination of glycosylated hemoglobin: effect of variant hemoglobins, hyperlipidemia, and temperature. Clin Chem 27 (1981) 472-475
13. Kosugi H., Kojima T., and Kikugawa K. Characteristics of the thiobarbituric acid reactivity of human urine as a possible consequence of lipid peroxidation. Lipids 28 (1993) 337-343
14. Agarwal R., and Chase S.D. Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B 775 (2002) 121-126
15. Winer B.J. Multifactor experiments having repeated measures on the same elements. In: Gramezy N. (Ed). Statistical principles in experimental design. 2nd ed. (1979), McGraw, New York 514-603
16. Snedecor G.W., and Cochran W.G. Regression. Statistical methods. 6 ed. (1967), Iowa University Press, Ames (Ia) 172-195
17. Hoeldtke R.D., Bryner K.D., Horvath G.G., et al. Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes. Diabetes 50 (2001) 436-443
18. Genovely H., and Pfeifer M.A. R-R-variation: the autonomic test of choice in diabetes. Diabetes Metab Rev 4 (1988) 255-271
19. Jara-Prado A., Ortega-Vazquez A., Martinez-Ruano L., et al. Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition. Neurotox Res 5 (2003) 237-243
20. El-Remessy A.B., Behzadian M.A., Abou-Mohamed G., et al. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 162 (2003) 1995-2004
21. Beisswenger P.J., Mauer M., Howell S., et al. Oxidative and dicarbonyl stress correlate with progression of diabetic nephropathy. Abstract. Diabetes 50 (2001) A6
22. Jain S.K., Kannan K., Lim G., et al. Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency. Diabetes 51 (2002) 2287-2293
23. Davi G., Giabattoni G., Consoli A., et al. In vivo formation of 8-iso-prostaglandin F2 alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99 (1999) 224-229
24. Vessby J., Basu S., Mohsen R., et al. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 251 (2002) 69-76
25. Hiramoto K., Ohkawa T., Oikawa N., et al. Is nitric oxide (NO) an antioxidant or a prooxidant for lipid peroxidation?. Chem Pharm Bull (Tokyo) 51 (2003) 1046-1050
26. Low P.A., Nickander K.K., and Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 Suppl 2 (1997) S38-S42
27. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9 (1990) 515-540
28. Tuncayengin A., Biri H., Onaran M., et al. Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in diabetic and non-diabetic erectile dysfunction. Int J Androl 26 (2003) 250-254
29. Hamdy O., and Abedlmoneim M. Lipid peroxidation could be related to the initiation and/or evolution of diabetic peripheral neuropathy in type II diabetics. Diabetes 44 Suppl (1995) 225A
30. O'Byrne S., Forte P., Roberts II L.J., et al. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes 49 (2000) 857-862
31. Keaney Jr. J.F., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress. Clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 23 (2003) 434-439
32. Prokai L., Prokai-Tatrai K., Perjesi P., et al. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci 100 (2003) 11741-11746
33. Cryer P.E. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350 (2004) 2272-2279
34. DeRosa M.A., and Cryer P.E. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab 287 (2004) E32-E41
35. Coppey L.J., Gellett J.S., Davidson E.P., et al. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50 (2001) 1927-1937
36. Marangon K., Devaraj S., Tirosh O., et al. Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress. Free Radic Biol Med 27 (1999) 1114-1121
37. Ametov A.S., Barinov A., Dyck P.J., et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 26 (2003) 770-776
38. Ziegler D., Nowak H., Kempler P., et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 21 (2004) 114-121
39. Bursell S.E., Clermont A.C., Aiello L.P., et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22 (1999) 1245-1251